Purple Biotech

A clinical-stage biotechnology company developing first-in-class therapies to overcome tumor immune evasion and drug resistance for cancer patients.

Health Tech & Life Sciences
public
Public Rehovot, Israel Founded 1968
Last updated 2026-10-29
Total raised
$151.3M
Stage
Public
Founded
1968
Headcount
10
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences

About

Purple Biotech Ltd. is an Israeli clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. The company is committed to developing first-in-class, effective therapies that harness the power of the tumor microenvironment to overcome drug resistance and improve treatment outcomes for cancer patients. Its oncology pipeline includes a preclinical tri-specific antibodies platform, CAPTN-3 (with therapeutic candidates IM1240 and IM1305), and two other oncology therapeutic candidates in clinical trial phases, CM24 and NT219. Purple Biotech was formerly known as Kitov Pharma Ltd. and changed its name in December 2020.

Funding history · 13 rounds · $151.3M total

13 events/rounds · $151.3M Total Funding: $10.0M in Private Equity, $141.3M in Public Equity
Sep 2025
Public Offering $2.3M EDGAR filing SEC-EDGAR 424B5
Jan 2025
Public Offering $1.3M EDGAR filing SEC-EDGAR 424B5
Jul 2024
Public Offering $2.0M EDGAR filing SEC-EDGAR 424B3
Mar 2022
Public Offering $21.0M EDGAR filing SEC-EDGAR 424B5
Jun 2021
Public Offering $50.0M EDGAR filing SEC-EDGAR 424B5
Jun 2020
Public Offering $35.0M EDGAR filing SEC-EDGAR 424B5
Jan 2019
Public Offering $6.0M EDGAR filing SEC-EDGAR 424B5
Jun 2018
Public Offering $8.2M EDGAR filing SEC-EDGAR 424B5
Jul 2017
Public Offering $3.5M EDGAR filing SEC-EDGAR 424B5
Jul 2016
Public Offering $12.0M EDGAR filing SEC-EDGAR 424B3
Dec 2015
Public Offering Undisclosed EDGAR filing SEC-EDGAR 424B3
Jun 2013
Public Offering Undisclosed prior (startupim db)
Dec 2011
Undisclosed Round $10.0M prior (startupim db)

Acquisitions · 3

Feb 2023
Immunorizon $100.0M
Jan 2020
FameWave Undisclosed
Oct 2017
TyrNovo Undisclosed

Offices

Rehovot, Israel · HQ / main office

Q&A

What is Purple Biotech's primary focus?
Purple Biotech is a clinical-stage biotechnology company focused on developing first-in-class therapies to overcome tumor immune evasion and drug resistance for cancer patients.
When was Purple Biotech founded and where is it headquartered?
Purple Biotech was founded in August 1968 and is headquartered in Rehovot, Israel.
What was Purple Biotech formerly known as?
Purple Biotech was formerly known as Kitov Pharma Ltd. and changed its name in December 2020.
What is the total amount of funding Purple Biotech has raised?
According to startupim data, Purple Biotech has raised a total of $164,306,035.8.
What is Purple Biotech's employee count?
Purple Biotech has 1-10 employees.
What are the key therapeutic candidates in Purple Biotech's oncology pipeline?
Purple Biotech's oncology pipeline includes a preclinical tri-specific antibodies platform, CAPTN-3 (with therapeutic candidates IM1240 and IM1305), and two other oncology therapeutic candidates in clinical trial phases, CM24 and NT219.
When did Purple Biotech complete its most recent public offering?
Purple Biotech completed a public offering in September 2025, raising $2,300,000.
Which company did Purple Biotech acquire in February 2023?
In February 2023, Purple Biotech acquired Immunorizon for $100,000,000.
Who is the Chief Executive Officer of Purple Biotech?
Gil Efron is the Chief Executive Officer of Purple Biotech.

Team · 15

Gil Efron
Chief Executive Officer
Hadas Reuveni
Vice President Research & Development
Michael Schickler
Head of Clinical and Regulatory Affairs
Shai Lankry
Chief Financial Officer
Eric Rowinsky
Chairman of the Board
Isaac Israel
Director
Ido Agmon
Director
Robert Gagnon
Director
Suzana Nahum-Zilberberg
Director
Yael Margolin
Director
Simcha Rock
Independent Director
Amir Horowitz
Scientific Advisory Board
Afshin Dowlati
Scientific Advisory Board
Alexander Shoushtari
Scientific Advisory Board
Max S. Topp
Scientific Advisory Board

Sectors & technology

Primary sector
Health Tech & Life Sciences
Technologies
Target customers
Business model
B2B

Highlights

Patents

Tags

immunotherapyantibodiespharmaceuticalsoncologycancercancer-therapydrug-developmentbiotechnologylife-sciences
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitepurple-biotech.com/
LinkedInlinkedin.com/company/6758085

Identifiers & details

Legal namePurple Biotech Ltd.
Founded1968-8
Employees (exact)10

Acquisitions & public offerings

AcquiredDateAmount
Immunorizon2023-02$100.0M
FameWave2020-01
TyrNovo2017-10

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domainpurple-biotech.com

Certificate / subdomain footprint

Subdomains2

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)520031238
Statusפעילה
Corp typeישראלית חברה ציבורית
Incorporated1968-08-12
Purposeלעסוק בסוגי עיסוק שפורטו בתקנון
Liabilityמוגבלת
In violation (unfiled)no
Last annual report1996
Active charges / liens0
Registry events0
Registered addressדרך בגין 132 תל אביב - יפו